2022 Frontiers in Neuroscience

2022 Frontiers in Neuroscience:

 

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

File Type: 848215
Categories: 2022
Tags: 2022, ACU193, oligomers, sabirnetug, TwentyTwentyTwo